Smoking Relapse during the First Year after Treatment for Early-Stage Non–Small-Cell Lung Cancer

Abstract
Background: Non–small-cell lung cancer patients who continue to smoke after cancer diagnosis are more likely to experience disease recurrence, decreased treatment efficacy, and treatment complications. Despite this, many continue to smoke, with estimates ranging from 13% to ∼60%.